The postprandial actions of GLP-1 receptor agonists: the missing link for cardiovascular and kidney protection in type 2 diabetes
Recent clinical trials in people with type 2 diabetes have demonstrated beneficial actions on
heart and kidney outcomes following treatment with GLP-1RAs. In part, these actions are …
heart and kidney outcomes following treatment with GLP-1RAs. In part, these actions are …
The CD40-CD40L dyad as immunotherapeutic target in cardiovascular disease
Chronic inflammation drives the development of atherosclerosis. Despite optimal treatment
of classical cardiovascular risk factors, a substantial portion of the population has elevated …
of classical cardiovascular risk factors, a substantial portion of the population has elevated …
[PDF][PDF] 系统炎症因子预测老年冠心病PCI 术后主要不良心脑血管事件的价值
周琦， 柯玲， 阮科， 明强 - 临床心血管病杂志, 2022 - whuhzzs.com
目的: 探讨系统炎症因子预测老年冠心病经皮冠状动脉介入术(PCI) 术后主要不良心脑血管事件(
MACCE) 的价值. 方法: 选取2017 年2 月—2020 年2 月我院老年冠心病并行PCI 治疗的患者85 …
MACCE) 的价值. 方法: 选取2017 年2 月—2020 年2 月我院老年冠心病并行PCI 治疗的患者85 …
The impact of SSRIs on mortality and cardiovascular events in patients with coronary artery disease and depression: systematic review and meta-analysis
Background Depression is common in patients after acute coronary syndromes (ACS) and
with stable coronary artery disease (CAD) and has been associated with increased mortality …
with stable coronary artery disease (CAD) and has been associated with increased mortality …
The effect of multistrain probiotics on functional constipation in the elderly: A randomized controlled trial
Background and objectives Constipation is one of the most common gastrointestinal
conditions, particularly among older individuals. This study aimed to evaluate the efficacy …
conditions, particularly among older individuals. This study aimed to evaluate the efficacy …
CD40/CD40L and related signaling pathways in cardiovascular health and disease—the pros and cons for cardioprotection
The CD40–CD40 ligand (CD40L) dyad represents a scientific and clinical field that has
raised many controversies in the past and cannot be clearly defined as being an either …
raised many controversies in the past and cannot be clearly defined as being an either …
Systemic inflammation and health outcomes in patients receiving treatment for atherosclerotic cardiovascular disease
Abstract Background and Aims The burden and outcomes of inflammation in patients with
atherosclerotic cardiovascular disease (ASCVD) are not well defined beyond the controlled …
atherosclerotic cardiovascular disease (ASCVD) are not well defined beyond the controlled …
ApoB-Specific CD4+ T Cells in Mouse and Human Atherosclerosis
T Marchini, S Hansen, D Wolf - Cells, 2021 - mdpi.com
Atherosclerosis is a chronic inflammatory condition of the arterial wall that leads to the
formation of vessel-occluding plaques within the subintimal space of middle-sized and …
formation of vessel-occluding plaques within the subintimal space of middle-sized and …
Anti-inflammatory strategies in atherosclerosis
H Bugger, A Zirlik - Hämostaseologie, 2021 - thieme-connect.com
Atherosclerotic vascular disease and its related complications are the major cause of
mortality in Western societies. Atherosclerosis is a chronic inflammatory disease of the …
mortality in Western societies. Atherosclerosis is a chronic inflammatory disease of the …
Effect of dual residual risk of cholesterol and inflammation on all-cause mortality in patients with cardiovascular disease
L Yang, Q Yue, F Fang, Y Zhang, P Liu, Z Zhang… - Cardiovascular …, 2023 - Springer
Background Randomized controlled trials confirm that risks of residual cholesterol and
residual inflammation remains in patients with cardiovascular disease (CVD) even after lipid …
residual inflammation remains in patients with cardiovascular disease (CVD) even after lipid …